Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillomavirus Type 16/18 Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06866574
What this trial is testing

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

Who this might be right for
Penile/Perineal /Perianal Intraepithelial NeoplasiaAnal Intraepithelial NeoplasiaPenile/Perianal/Perineal Cancer+2 more
Xiamen University 9,300
Large-scale testing (Phase 3)Study completedNCT02576054
What this trial is testing

Safety and Tolerability Study of V501 in Japanese Boys (V501-200)

Who this might be right for
Anogenital Human Papilloma Virus InfectionCondyloma Acuminata
Merck Sharp & Dohme LLC 101
Large-scale testing (Phase 3)Active Not RecruitingNCT04199689
What this trial is testing

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 6,033
Not applicableActive Not RecruitingNCT00867464
What this trial is testing

Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

Who this might be right for
Anal CarcinomaCervical CarcinomaHuman Papillomavirus Infection+2 more
National Cancer Institute (NCI) 8,670
Not applicableEnded earlyNCT01355003
What this trial is testing

GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,080
Large-scale testing (Phase 3)Study completedNCT00092534
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 12,167
Large-scale testing (Phase 3)Study completedNCT00092547
What this trial is testing

Gardasil (V501) in Preadolescents and Adolescents (V501-018)

Who this might be right for
HumanPapillomavirus Infections
Merck Sharp & Dohme LLC 1,781
Large-scale testing (Phase 3)UnknownNCT05580341
What this trial is testing

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Who this might be right for
Cervical CancerGenital WartCIN+2 more
Shanghai Zerun Biotechnology Co.,Ltd 1,200
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Testing effectiveness (Phase 2)Study completedNCT00693615
What this trial is testing

Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 60
Large-scale testing (Phase 3)Study completedNCT02562508
What this trial is testing

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 979
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Post-approval studies (Phase 4)UnknownNCT05279248
What this trial is testing

The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Measles+2 more
Zhejiang Provincial Center for Disease Control and Prevention 300
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Not applicableStudy completedNCT06919627
What this trial is testing

Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)

Who this might be right for
Cervical CancersPapillomavirus InfectionsPapillomavirus Type 16/18 Infection
University Hospital, Brest 45
Testing effectiveness (Phase 2)Study completedNCT02740790
What this trial is testing

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

Who this might be right for
Human Papillomavirus
Shanghai Zerun Biotechnology Co.,Ltd 1,200
Large-scale testing (Phase 3)Study completedNCT00337818
What this trial is testing

Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

Who this might be right for
Papillomavirus Type 16/18 InfectionCervical Intraepithelial Neoplasia
GlaxoSmithKline 770
Testing effectiveness (Phase 2)Study completedNCT02740777
What this trial is testing

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Who this might be right for
Human PapillomavirusCervical Intraepithelial NeoplasiaPersistent Infection
Shanghai Zerun Biotechnology Co.,Ltd 900
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Early research (Phase 1)UnknownNCT01548118
What this trial is testing

Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females

Who this might be right for
Human Papillomavirus
Shanghai Zerun Biotechnology Co.,Ltd 160
Next Page